Oral poliovaccine viruses can undergo multiple genetic changes during replication in humans, which may contribute to the restoration of neurovirulence.
Answers are grounded in this paper and cite their sources.
May signal OPV reversion risk in humans; leaves open whether changes restore clinical neurovirulence.
Poliovirus isolates of serotypes 2 and 3 from patients whose paralytic poliomyelitis cases were classified as oral vaccine-associated were analysed by oligonucleotide mapping of the virus genomes and by polyacrylamide gel electrophoresis of the virus proteins. Oligonucleotide maps of all isolates were similar to the maps of the corresponding oral vaccine strain. No two isolates gave identical maps. Most maps differed from that of the vaccine strain by at least one oligonucleotide spot. Maps of some isolates revealed numerous differences, indicating that multiple (greater than 100) genetic changes had occurred in the vaccine virus genomes during replication in one or two individuals. In contrast, maps of some neural tissue isolates showed minimal differences from the reference vaccine maps, raising the possibility that neurovirulence may be restored by a small number of genetic changes. For many isolates, changes were also detected in the mobilities of processing rates of the virus proteins.
No takes yet. Share an insight, caveat, or question.
Kew et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: